16-21258783-A-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM4BS2
The NM_001376256.1(CRYM):āc.943T>Cā(p.Ter315GlnextTer5) variant causes a stop lost change. The variant allele was found at a frequency of 0.0000335 in 1,613,626 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00020 ( 0 hom., cov: 32)
Exomes š: 0.000016 ( 0 hom. )
Consequence
CRYM
NM_001376256.1 stop_lost
NM_001376256.1 stop_lost
Scores
3
4
Clinical Significance
Conservation
PhyloP100: 5.00
Genes affected
CRYM (HGNC:2418): (crystallin mu) Crystallins are separated into two classes: taxon-specific and ubiquitous. The former class is also called phylogenetically-restricted crystallins. The latter class constitutes the major proteins of vertebrate eye lens and maintains the transparency and refractive index of the lens. This gene encodes a taxon-specific crystallin protein that binds NADPH and has sequence similarity to bacterial ornithine cyclodeaminases. The encoded protein does not perform a structural role in lens tissue, and instead it binds thyroid hormone for possible regulatory or developmental roles. Mutations in this gene have been associated with autosomal dominant non-syndromic deafness. [provided by RefSeq, Sep 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM4
Stoplost variant in NM_001376256.1 Downstream stopcodon found after 32 codons.
BS2
High AC in GnomAd4 at 30 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CRYM | NM_001376256.1 | c.943T>C | p.Ter315GlnextTer5 | stop_lost | 8/8 | ENST00000572914.2 | NP_001363185.1 | |
CRYM | NM_001888.5 | c.943T>C | p.Ter315GlnextTer5 | stop_lost | 10/10 | NP_001879.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CRYM | ENST00000572914.2 | c.943T>C | p.Ter315GlnextTer5 | stop_lost | 8/8 | 2 | NM_001376256.1 | ENSP00000461904 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 30AN: 152212Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
30
AN:
152212
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000796 AC: 20AN: 251206Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135762
GnomAD3 exomes
AF:
AC:
20
AN:
251206
Hom.:
AF XY:
AC XY:
4
AN XY:
135762
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000164 AC: 24AN: 1461296Hom.: 0 Cov.: 30 AF XY: 0.0000151 AC XY: 11AN XY: 727018
GnomAD4 exome
AF:
AC:
24
AN:
1461296
Hom.:
Cov.:
30
AF XY:
AC XY:
11
AN XY:
727018
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000197 AC: 30AN: 152330Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74472
GnomAD4 genome
AF:
AC:
30
AN:
152330
Hom.:
Cov.:
32
AF XY:
AC XY:
9
AN XY:
74472
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
7
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
12
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Autosomal dominant nonsyndromic hearing loss 40 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | New York Genome Center | Sep 26, 2019 | The inherited c.943T>C (p.Ter315GlnextTer5) variant identified in the CRYM gene is a stop loss which substitutes the stop codon (amino acid 315/315; coding exon 10/10) for a Glutamine, which is predicted to extend the protein by 5 C-terminal amino acids. This variant is found with low frequency in gnomAD (22 heterozygotes, 0 homozygotes; allele frequency: 7.79e-5) and ExAC (12 heterozygotes, 0 homozygotes; allele frequency: 9.89e-5), suggesting it is not a common benign variant in the populations represented in these databases. This variant is absent from ClinVar, however a different amino acid change at the same amino acid (c.945A>T; p.Ter315TyrextTer5) has been reported as pathogenic (VarID:16934). While the p.Ter315GlnextTer5 identified here has not been reported in affected individuals in the literature, the p.Ter315TyrextTer5 variant reported in ClinVar has been identified as a de novo variant in an individual with bilateral moderate sensorineural hearing loss affecting all frequencies [PMID: 12471561], and in vitro functional studies suggested this variant may lead to mislocalization of the CRYM protein to the cytoplasm [PMID: 16740909]. While studies supporting the pathogenicity of the p.Ter315TyrextTer5 variant are promising, the lack of affected individuals reported or functional evidence supporting the pathogenicity of the c.943T>C (p.Ter315GlnextTer5) variant identified here leads to its classification as a Variant of Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
MutationTaster
Benign
N;N;N;N
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at